ZoomMed Announces the Grant of Options

ZoomMed inc. announces that its Board of directors agreed to grant 1,400,000 stock options to its directors and officers and 1,385,000 stock options to its employees and consultants taking effect on October 17, 2008.

Each of these options allows its holder to purchase a common share of ZoomMed at a price of $0.20 for a five (5) year period following their issuance, subject to the provisions of the stock option plan of ZoomMed and TSX Venture Exchange policies.

For more information on ZOOMMED or the "ZRx Prescriber", please visit our website: www.zoommed.com.

The TSX Venture Exchange does not assume any responsibility as for the relevance or with the exactitude of this press release.